Symbol:
Agpat4
Name:
1-acylglycerol-3-phosphate O-acyltransferase 4
RGD ID:
619916
Description:
Predicted to enable 1-acylglycerol-3-phosphate O-acyltransferase activity. Predicted to be involved in phospholipid metabolic process. Predicted to be located in endoplasmic reticulum. Predicted to be active in endomembrane system and mitochondrial outer membrane. Orthologous to human AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4); PARTICIPATES IN glycerolipid metabolic pathway; glycerophospholipid metabolic pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; acetamide.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
1-acyl-sn-glycerol-3-phosphate acyltransferase delta; 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase delta); 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, delta); 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta); 1-AGP acyltransferase 4; 1-AGPAT 4; LPAAT-delta; lysophosphatidic acid acyltransferase delta; MGC93227
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Agpat4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Agpat4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Agpat4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Agpat4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
PRSS38 (serine protease 38)
HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Agpat4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
agpat4 (1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta))
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Agpat3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Agpat4
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
YDR018C
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoInspector|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
CST26
Alliance
DIOPT (Hieranoid|InParanoid|OrthoInspector|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
agpat4
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 51,075,081 - 51,181,548 (-) NCBI GRCr8 mRatBN7.2 1 48,525,131 - 48,633,798 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 48,527,323 - 48,633,345 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 49,218,910 - 49,324,839 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 55,203,981 - 55,309,606 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 49,294,411 - 49,400,333 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 48,716,094 - 48,826,292 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 48,719,633 - 48,825,364 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 50,929,133 - 51,035,499 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 42,986,809 - 43,096,390 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 42,989,754 - 43,099,335 (-) NCBI Celera 1 44,317,112 - 44,422,634 (-) NCBI Celera Cytogenetic Map 1 q11 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Agpat4 Rat 1,2-dimethylhydrazine multiple interactions ISO Agpat4 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGPAT4 mRNA CTD PMID:22206623 Agpat4 Rat 1,2-dimethylhydrazine decreases expression ISO Agpat4 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of AGPAT4 mRNA CTD PMID:22206623 Agpat4 Rat 17alpha-ethynylestradiol multiple interactions ISO Agpat4 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGPAT4 mRNA CTD PMID:17942748 Agpat4 Rat 17beta-estradiol multiple interactions ISO AGPAT4 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of AGPAT4 mRNA CTD PMID:17404688 Agpat4 Rat 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO Agpat4 (Mus musculus) 6480464 2 more ... CTD PMID:20005886 Agpat4 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Agpat4 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGPAT4 mRNA CTD PMID:17942748 Agpat4 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AGPAT4 mRNA CTD PMID:33387578 Agpat4 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AGPAT4 mRNA CTD PMID:34747641 Agpat4 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Agpat4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of AGPAT4 mRNA CTD PMID:28238261 Agpat4 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Agpat4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of AGPAT4 mRNA CTD PMID:21354282 Agpat4 Rat 2-hydroxypropanoic acid decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of AGPAT4 mRNA CTD PMID:30851411 Agpat4 Rat 2-methylcholine affects expression ISO AGPAT4 (Homo sapiens) 6480464 beta-methylcholine affects the expression of AGPAT4 mRNA CTD PMID:21179406 Agpat4 Rat 4,4'-sulfonyldiphenol multiple interactions ISO AGPAT4 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of AGPAT4 gene CTD PMID:31601247 Agpat4 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT4 mRNA CTD PMID:36041667 Agpat4 Rat 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO AGPAT4 (Homo sapiens) 6480464 Am 580 results in increased expression of AGPAT4 mRNA CTD PMID:16982809 Agpat4 Rat 4-hydroxyphenyl retinamide decreases expression ISO Agpat4 (Mus musculus) 6480464 Fenretinide results in decreased expression of AGPAT4 mRNA CTD PMID:28973697 Agpat4 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of AGPAT4 mRNA CTD PMID:31881176 Agpat4 Rat all-trans-retinoic acid decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Tretinoin results in decreased expression of AGPAT4 mRNA CTD PMID:33167477 Agpat4 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AGPAT4 mRNA CTD PMID:16483693 Agpat4 Rat aristolochic acid A decreases expression ISO AGPAT4 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of AGPAT4 mRNA CTD PMID:33212167 Agpat4 Rat arsenous acid increases expression ISO AGPAT4 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of AGPAT4 mRNA CTD PMID:21461292 Agpat4 Rat benzo[a]pyrene decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of AGPAT4 mRNA CTD PMID:20064835 Agpat4 Rat benzo[a]pyrene decreases methylation ISO AGPAT4 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of AGPAT4 promoter CTD PMID:27901495 Agpat4 Rat benzo[a]pyrene affects methylation ISO AGPAT4 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AGPAT4 5' UTR CTD PMID:27901495 Agpat4 Rat benzo[a]pyrene increases expression ISO Agpat4 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of AGPAT4 mRNA CTD PMID:32417428 Agpat4 Rat benzo[a]pyrene diol epoxide I decreases expression ISO AGPAT4 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 Agpat4 Rat bis(2-ethylhexyl) phthalate decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of AGPAT4 mRNA CTD PMID:31163220 Agpat4 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Agpat4 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of AGPAT4 mRNA CTD PMID:34319233 Agpat4 Rat bisphenol A decreases expression ISO AGPAT4 (Homo sapiens) 6480464 bisphenol A results in decreased expression of AGPAT4 mRNA CTD PMID:25047013 Agpat4 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT4 mRNA CTD PMID:36041667 Agpat4 Rat bisphenol A affects methylation ISO AGPAT4 (Homo sapiens) 6480464 bisphenol A affects the methylation of AGPAT4 gene CTD PMID:31601247 Agpat4 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AGPAT4 mRNA CTD PMID:30816183 and PMID:34947998 Agpat4 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AGPAT4 mRNA CTD PMID:25181051 Agpat4 Rat bisphenol A decreases expression ISO Agpat4 (Mus musculus) 6480464 bisphenol A results in decreased expression of AGPAT4 mRNA CTD PMID:26063408 Agpat4 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT4 mRNA CTD PMID:36041667 Agpat4 Rat CGP 52608 multiple interactions ISO AGPAT4 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to AGPAT4 gene] CTD PMID:28238834 Agpat4 Rat choline multiple interactions ISO Agpat4 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AGPAT4 mRNA CTD PMID:20938992 Agpat4 Rat cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of AGPAT4 mRNA CTD PMID:22023808 Agpat4 Rat cisplatin multiple interactions ISO AGPAT4 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of AGPAT4 mRNA CTD PMID:27392435 Agpat4 Rat copper(II) chloride decreases expression ISO AGPAT4 (Homo sapiens) 6480464 cupric chloride results in decreased expression of AGPAT4 mRNA CTD PMID:38568856 Agpat4 Rat copper(II) sulfate increases expression ISO AGPAT4 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of AGPAT4 mRNA CTD PMID:19549813 Agpat4 Rat crocidolite asbestos decreases expression ISO Agpat4 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of AGPAT4 mRNA CTD PMID:29279043 Agpat4 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of AGPAT4 mRNA CTD PMID:27523638 Agpat4 Rat dexamethasone decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of AGPAT4 mRNA CTD PMID:25047013 Agpat4 Rat diarsenic trioxide increases expression ISO AGPAT4 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of AGPAT4 mRNA CTD PMID:21461292 Agpat4 Rat Dibutyl phosphate affects expression ISO AGPAT4 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of AGPAT4 mRNA CTD PMID:37042841 Agpat4 Rat doxorubicin decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of AGPAT4 mRNA CTD PMID:29803840 Agpat4 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of AGPAT4 mRNA CTD PMID:29391264 Agpat4 Rat ethanol increases expression ISO Agpat4 (Mus musculus) 6480464 Ethanol results in increased expression of AGPAT4 mRNA CTD PMID:19167417 Agpat4 Rat folic acid multiple interactions ISO Agpat4 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Agpat4 Rat fulvestrant multiple interactions ISO AGPAT4 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of AGPAT4 gene CTD PMID:31601247 Agpat4 Rat furan increases expression EXP 6480464 furan results in increased expression of AGPAT4 mRNA CTD PMID:27387713 Agpat4 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of AGPAT4 mRNA CTD PMID:22061828 Agpat4 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AGPAT4 mRNA CTD PMID:33387578 Agpat4 Rat indometacin increases expression EXP 6480464 Indomethacin results in increased expression of AGPAT4 mRNA CTD PMID:36868495 Agpat4 Rat irinotecan affects expression EXP 6480464 Irinotecan affects the expression of AGPAT4 mRNA CTD PMID:20097248 Agpat4 Rat L-methionine multiple interactions ISO Agpat4 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AGPAT4 mRNA CTD PMID:20938992 Agpat4 Rat methylmercury chloride decreases expression ISO AGPAT4 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of AGPAT4 mRNA CTD PMID:28001369 Agpat4 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of AGPAT4 mRNA CTD PMID:25729387 Agpat4 Rat paracetamol affects expression ISO Agpat4 (Mus musculus) 6480464 Acetaminophen affects the expression of AGPAT4 mRNA CTD PMID:17562736 Agpat4 Rat potassium chromate decreases expression ISO AGPAT4 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of AGPAT4 mRNA CTD PMID:22714537 Agpat4 Rat progesterone multiple interactions ISO AGPAT4 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of AGPAT4 mRNA CTD PMID:17404688 Agpat4 Rat rac-lactic acid decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of AGPAT4 mRNA CTD PMID:30851411 Agpat4 Rat resveratrol increases expression ISO Agpat4 (Mus musculus) 6480464 resveratrol results in increased expression of AGPAT4 protein CTD PMID:25505154 Agpat4 Rat silicon dioxide decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of AGPAT4 mRNA CTD PMID:25895662 Agpat4 Rat sodium arsenite affects methylation ISO AGPAT4 (Homo sapiens) 6480464 sodium arsenite affects the methylation of AGPAT4 gene CTD PMID:28589171 Agpat4 Rat sodium arsenite decreases expression ISO AGPAT4 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of AGPAT4 mRNA CTD PMID:38568856 Agpat4 Rat tetracycline decreases expression ISO Agpat4 (Mus musculus) 6480464 Tetracycline results in decreased expression of AGPAT4 mRNA CTD PMID:16917069 Agpat4 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AGPAT4 mRNA CTD PMID:34492290 Agpat4 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of AGPAT4 mRNA CTD PMID:25729387 Agpat4 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of AGPAT4 mRNA CTD PMID:25729387 Agpat4 Rat triptonide decreases expression ISO Agpat4 (Mus musculus) 6480464 triptonide results in decreased expression of AGPAT4 mRNA CTD PMID:33045310 Agpat4 Rat valproic acid decreases expression ISO AGPAT4 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AGPAT4 mRNA CTD PMID:23179753 and PMID:28001369 Agpat4 Rat valproic acid affects expression ISO AGPAT4 (Homo sapiens) 6480464 Valproic Acid affects the expression of AGPAT4 mRNA CTD PMID:25979313 Agpat4 Rat valproic acid increases expression ISO AGPAT4 (Homo sapiens) 6480464 Valproic Acid results in increased expression of AGPAT4 mRNA CTD PMID:29154799 Agpat4 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of AGPAT4 mRNA CTD PMID:23034163
Imported Annotations - KEGG (archival)
1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-hydroxypropanoic acid (ISO) 2-methylcholine (ISO) 4,4'-sulfonyldiphenol (EXP,ISO) 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid (ISO) 4-hydroxyphenyl retinamide (ISO) acetamide (EXP) all-trans-retinoic acid (ISO) ammonium chloride (EXP) aristolochic acid A (ISO) arsenous acid (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP) CGP 52608 (ISO) choline (ISO) cisplatin (EXP,ISO) copper(II) chloride (ISO) copper(II) sulfate (ISO) crocidolite asbestos (ISO) Cuprizon (EXP) dexamethasone (ISO) diarsenic trioxide (ISO) Dibutyl phosphate (ISO) doxorubicin (ISO) endosulfan (EXP) ethanol (ISO) folic acid (ISO) fulvestrant (ISO) furan (EXP) gentamycin (EXP) indometacin (EXP) irinotecan (EXP) L-methionine (ISO) methylmercury chloride (ISO) oxaliplatin (EXP) paracetamol (ISO) potassium chromate (ISO) progesterone (ISO) rac-lactic acid (ISO) resveratrol (ISO) silicon dioxide (ISO) sodium arsenite (ISO) tetracycline (ISO) thioacetamide (EXP) topotecan (EXP) triptonide (ISO) valproic acid (ISO) vinclozolin (EXP)
Agpat4 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 51,075,081 - 51,181,548 (-) NCBI GRCr8 mRatBN7.2 1 48,525,131 - 48,633,798 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 48,527,323 - 48,633,345 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 49,218,910 - 49,324,839 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 55,203,981 - 55,309,606 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 49,294,411 - 49,400,333 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 48,716,094 - 48,826,292 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 48,719,633 - 48,825,364 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 50,929,133 - 51,035,499 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 42,986,809 - 43,096,390 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 42,989,754 - 43,099,335 (-) NCBI Celera 1 44,317,112 - 44,422,634 (-) NCBI Celera Cytogenetic Map 1 q11 NCBI
AGPAT4 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 161,129,967 - 161,274,061 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 161,129,967 - 161,274,061 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 161,550,999 - 161,695,093 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 161,471,047 - 161,615,097 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 6 161,527,517 - 161,665,448 NCBI Celera 6 162,280,457 - 162,424,409 (-) NCBI Celera Cytogenetic Map 6 q26 NCBI HuRef 6 159,006,418 - 159,150,408 (-) NCBI HuRef CHM1_1 6 161,813,702 - 161,957,597 (-) NCBI CHM1_1 T2T-CHM13v2.0 6 162,488,365 - 162,632,384 (-) NCBI T2T-CHM13v2.0
Agpat4 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 17 12,337,372 - 12,438,536 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 17 12,337,591 - 12,438,532 (+) Ensembl GRCm39 Ensembl GRCm38 17 12,118,485 - 12,219,649 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 17 12,118,704 - 12,219,645 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 17 12,312,150 - 12,412,506 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 17 11,962,642 - 12,062,998 (+) NCBI MGSCv36 mm8 Celera 17 12,147,922 - 12,252,652 (+) NCBI Celera Cytogenetic Map 17 A1 NCBI cM Map 17 8.33 NCBI
Agpat4 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955439 20,050,619 - 20,132,893 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955439 20,050,619 - 20,132,893 (+) NCBI ChiLan1.0 ChiLan1.0
AGPAT4 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 5 181,305,186 - 181,450,074 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 6 179,210,769 - 179,355,480 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 6 159,075,360 - 159,219,887 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 6 164,085,970 - 164,229,696 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 6 164,092,522 - 164,229,696 (-) Ensembl panpan1.1 panPan2
AGPAT4 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 1 49,709,437 - 49,837,848 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 1 49,709,741 - 49,837,091 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 1 50,552,643 - 50,680,914 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 1 49,894,606 - 50,022,389 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 1 49,894,612 - 50,023,044 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 1 49,776,903 - 49,904,869 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 1 49,647,989 - 49,776,147 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 1 50,264,213 - 50,392,536 (-) NCBI UU_Cfam_GSD_1.0
Agpat4 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404946 144,730,179 - 144,826,056 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936489 11,981,969 - 12,042,447 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936489 11,982,488 - 12,078,132 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
AGPAT4 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 6,772,417 - 6,883,551 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 6,761,734 - 6,883,555 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 8,330,534 - 8,440,346 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
AGPAT4 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 13 88,634,100 - 88,782,371 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 13 88,640,548 - 88,781,702 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666040 60,965,050 - 61,111,779 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Agpat4 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 66 Count of miRNA genes: 55 Interacting mature miRNAs: 63 Transcripts: ENSRNOT00000024213 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1331732 Srn4 Serum renin concentration QTL 4 4.467 renin activity (VT:0005581) plasma renin activity level (CMO:0000116) 1 35239598 78430678 Rat 2313059 Bss55 Bone structure and strength QTL 55 3.2 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 1 43284731 118944897 Rat 631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 3 0.0001 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 5925874 115540829 Rat 1357397 Bw41 Body weight QTL 41 4.19 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 1 22340647 49361612 Rat 1358359 Sradr1 Stress Responsive Adrenal Weight QTL 1 4.74 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 1 30882023 123479925 Rat 1331792 Rf29 Renal function QTL 29 4.589 urine potassium amount (VT:0010539) urine potassium level (CMO:0000128) 1 35239598 78430678 Rat 2313062 Bmd73 Bone mineral density QTL 73 3.9 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 11481312 82174945 Rat 8552900 Pigfal1 Plasma insulin-like growth factor 1 level QTL 1 7.4 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 1 34836858 79836858 Rat 1554320 Bmd1 Bone mineral density QTL 1 12.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 509108 86060548 Rat 1354643 Foco2 Food consumption QTL 2 7.17 0.0001 eating behavior trait (VT:0001431) food intake rate (CMO:0000427) 1 33449848 78449848 Rat 2302059 Pia36 Pristane induced arthritis QTL 36 3.8 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 1 43333002 88333002 Rat 2313065 Bss67 Bone structure and strength QTL 67 3.1 0.0001 tibia area (VT:1000281) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 7421626 Bp360 Blood pressure QTL 360 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 4393289 49393289 Rat 1357400 Bw62 Body weight QTL62 4.05 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 1 22340647 67340647 Rat 1357401 Bw43 Body weight QTL 43 3.75 body mass (VT:0001259) body weight (CMO:0000012) 1 22340647 49361612 Rat 2313069 Bss68 Bone structure and strength QTL 68 2.9 0.0001 tibia size trait (VT:0100001) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 631495 Bp96 Blood pressure QTL 96 4.52 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 22340647 102268831 Rat 631494 Bp95 Blood pressure QTL 95 40 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 16206210 49268520 Rat 2313075 Bss66 Bone structure and strength QTL 66 3.4 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 11481312 82174945 Rat 5684998 Bss101 Bone structure and strength QTL 101 3.6 tibia strength trait (VT:1000284) tibia ultimate force (CMO:0001734) 1 15431621 49361612 Rat 70225 Bp58 Blood pressure QTL 58 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32356093 162846471 Rat 5684999 Bss102 Bone structure and strength QTL 102 5.5 7e-07 tibia strength trait (VT:1000284) tibia stiffness (CMO:0001735) 1 15431621 49361612 Rat 2313072 Bss53 Bone structure and strength QTL 53 4.3 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 43284731 118944897 Rat 1300167 Hrtrt2 Heart rate QTL 2 4.35 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 11481312 75088344 Rat 10059597 Bp377 Blood pressure QTL 377 3.42 0.025 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32737458 199368955 Rat 2313078 Bss54 Bone structure and strength QTL 54 3.5 0.0001 tibia area (VT:1000281) tibia midshaft cross-sectional area (CMO:0001717) 1 43284731 118944897 Rat 2313077 Bss69 Bone structure and strength QTL 69 3.5 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 11481312 82174945 Rat 1331778 Rf28 Renal function QTL 28 4.66 urine potassium amount (VT:0010539) urine potassium excretion rate (CMO:0000761) 1 45803140 78430678 Rat 1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 2.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 11835181 56835181 Rat 631508 Sald1 Serum aldosterone level QTL 1 3.7 blood aldosterone amount (VT:0005346) serum aldosterone level (CMO:0000487) 1 9856001 54856001 Rat 1331785 Rf27 Renal function QTL 27 4.643 urine sodium amount (VT:0006274) urine sodium level (CMO:0000129) 1 28879780 78430678 Rat 1300172 Bp172 Blood pressure QTL 172 3.56 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 32737273 90665040 Rat 724520 Bp145 Blood pressure QTL 145 2.1 0.0024 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 20784828 65784828 Rat 2313094 Bss58 Bone structure and strength QTL 58 3.7 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 43284731 118944897 Rat 2313092 Bmd72 Bone mineral density QTL 72 2.5 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 1 11481312 82174945 Rat 2313099 Bss56 Bone structure and strength QTL 56 2.4 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 1 43284731 118944897 Rat 2313098 Bmd70 Bone mineral density QTL 70 3.6 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 43284731 118944897 Rat 2313097 Bss70 Bone structure and strength QTL 70 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 9589820 Insglur3 Insulin/glucose ratio QTL 3 10.75 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 1 34836858 79836858 Rat 738020 Pia8 Pristane induced arthritis QTL 8 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 1 1 65833076 Rat 1354599 Bw29 Body weight QTL 29 3.46 0.001 body mass (VT:0001259) body weight (CMO:0000012) 1 33449848 78449848 Rat 2302038 Pia31 Pristane induced arthritis QTL 31 5.5 0.001 blood autoantibody amount (VT:0003725) serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) 1 10992065 55992065 Rat 8552948 Pigfal11 Plasma insulin-like growth factor 1 level QTL 11 4.7 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 1 34836858 79836858 Rat 634353 Rends2 Renal damage susceptibility QTL 2 0.05 kidney blood vessel morphology trait (VT:0000530) organ lesion measurement (CMO:0000677) 1 19333571 56983283 Rat 2313051 Bss57 Bone structure and strength QTL 57 3.7 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 43284731 118944897 Rat
RH135066
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 48,527,410 - 48,527,604 (+) MAPPER mRatBN7.2 Rnor_6.0 1 48,719,721 - 48,719,914 NCBI Rnor6.0 Rnor_5.0 1 51,035,217 - 51,035,410 UniSTS Rnor5.0 RGSC_v3.4 1 42,986,898 - 42,987,091 UniSTS RGSC3.4 Celera 1 44,317,201 - 44,317,394 UniSTS RH 3.4 Map 1 572.9 UniSTS Cytogenetic Map 1 q11 UniSTS
BF415643
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 48,584,748 - 48,584,917 (+) MAPPER mRatBN7.2 Rnor_6.0 1 48,776,921 - 48,777,089 NCBI Rnor6.0 Rnor_5.0 1 50,978,455 - 50,978,623 UniSTS Rnor5.0 RGSC_v3.4 1 43,045,145 - 43,045,313 UniSTS RGSC3.4 Celera 1 44,374,346 - 44,374,514 UniSTS RH 3.4 Map 1 586.7 UniSTS Cytogenetic Map 1 q11 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000024213 ⟹ ENSRNOP00000024213
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 48,527,325 - 48,633,238 (-) Ensembl Rnor_6.0 Ensembl 1 48,719,633 - 48,825,364 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000082958 ⟹ ENSRNOP00000069883
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 48,527,323 - 48,633,345 (-) Ensembl Rnor_6.0 Ensembl 1 48,719,942 - 48,797,631 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000117069 ⟹ ENSRNOP00000094231
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 48,527,325 - 48,633,238 (-) Ensembl
RefSeq Acc Id:
NM_133406 ⟹ NP_596897
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 51,075,081 - 51,180,971 (-) NCBI mRatBN7.2 1 48,527,322 - 48,633,223 (-) NCBI Rnor_6.0 1 48,719,632 - 48,825,378 (-) NCBI Rnor_5.0 1 50,929,133 - 51,035,499 (+) NCBI RGSC_v3.4 1 42,986,809 - 43,096,390 (-) RGD Celera 1 44,317,112 - 44,422,634 (-) RGD
Sequence:
CTCGCTTTTTCTTTCCAGTGTTGGCTGACTTACAGCTTCTCTAAAGTAGAGGCAGTTTCTGAACCCTAGGTTCCTGCCTCGCAGTTCTGGCTAGTGAGCACCAATGCAAAGAGCTGCCCGGAGCGAGA CGGTTTCCTGAGCCCCGGATCTTTCTCCCTTCTGGAACTATTCCGCCATGCGTACTTGTCTCTTGAGAATCCCCGCATCATGGACCTCATCGGGCTGCTGAAGTCCCAGTTTCTGTGTCACCTGGTCT TCTGCTACGTGTTCATCGCCTCCGGGCTCATTGTCAACGCCATCCAGCTGTGCACGCTGGTCATCTGGCCCATCAACAAGCAGCTGTTCCGAAAGATAAACGCCAGACTCTGCTACTGCGTCTCCAGC CAGTTGGTGATGCTTCTGGAGTGGTGGTCAGGTACGGAGTGTACCATCTACACCGACCCGAAGGCCTCCCCCCACTACGGGAAGGAAAACGCCATCGTGGTTCTCAATCACAAGTTTGAGATTGACTT TCTCTGTGGCTGGAGCCTGGCTGAGCGCCTAGGGATCCTGGGGAACTCCAAAGTCCTGGCCAAGAAAGAACTGGCTTATGTCCCCATCATTGGCTGGATGTGGTACTTTGTGGAAATGATCTTCTGCA CACGCAAGTGGGAGCAAGATCGGCAGACGGTTGCCAAGAGCCTGCTGCACCTCCGGGACTACCCAGAGAAGTATCTGTTTCTGATCCACTGTGAGGGCACACGGTTCACAGAGAAGAAACACCAAATC AGCATGCAGGTGGCCCAAGCCAAGGGGCTGCCCAGCCTCAAGCATCACCTGCTGCCACGCACCAAGGGCTTTGCTATCACTGTGAAGTGCTTGCGAGATGTTGTCCCAGCCGTATATGACTGTACACT CAATTTCAGAAACAATGAAAACCCAACACTGCTGGGAGTCTTAAATGGAAAGAAATATCACGCTGACTGCTACGTTAGGAGGATCCCCATGGAAGACATCCCTGAGGATGAGGACAAGTGCTCAGCCT GGCTACACAAGCTCTACCAGGAGAAGGATGCCTTTCAGGAGGAATACTACAGGACAGGGGTCTTCCCAGAGACTCCCTGGGTTCCCCCACGGCGGCCCTGGTCTCTGGTCAACTGGTTGTTCTGGGCG TCGTTGCTGCTCTATCCTTTCTTCCAGTTCCTTGTTAGCATGGTCAGCAGCGGTTCCTCGGTGACGCTGGCCAGCTTGGTCCTCATCTTCTGCATGGCCTCCATGGGAGTTCGATGGATGATTGGTGT GACAGAAATCGACAAGGGCTCTGCCTATGGCAACATCGACAACAAACGGAAACAAACTGACTGATGTGGAAAATGTCACCTCCAAAGGGAACCGTGGGGGACAGTTGGCCTCTGCTTAGCCTTTATAG CAGGGTTCAGTGATGGAGACTGGAGGGCCTTGCTGGGGCAAACAGAAACCACAGCCCCTCCAGTCATGGAGTTTGCCTTGGCGCTGGATGGGAAAGGAAGATGGTTTTATACCTTTCCCCTCCCCCAT CCCCCGTGTGAATTACTGGGTTTGGTTAACGTTTCTTTTCAGTTGCAACACGTGTTTGTGTGTATGTGTGTGTGAGAGAGATGGGGGTGAGGAGAATGAGTGTGTGGTTGCGTGTGCACTTGTGACCC TGTGACAGTAGGGTCTGTGAGGCTGCAGGGAAGGGCAGGGCTGGGGTGGAAGAGAAGGTGTGTGTCCCTGTCATCCCGTGGTGCTGCGTCTTCTCTAACCATCGATCGCTGGAGACGGAGTGAAGTGT TTGGGTAAGACAACTAAATTATGCCTCCAAATAAGAAAAAGAATTAAAGTGTTTGTCTGGGTCAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006227856 ⟹ XP_006227918
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 51,075,081 - 51,154,717 (-) NCBI mRatBN7.2 1 48,525,131 - 48,605,505 (-) NCBI Rnor_6.0 1 48,716,094 - 48,798,471 (-) NCBI Rnor_5.0 1 50,929,133 - 51,035,499 (+) NCBI
Sequence:
CATGCGCACACAGCGCCCACAGATGCCAGAACACAGCATCAGAACCCCTAGCATGGGAGTTACAGATGCTTGTGAGTCACAGTACGTGTGCTTGGAATTGAACCAGGTCTTCTGTGGGAACAGAAAGT GCTATCTCACCAGCCCGGTCATTTCAGTTTCTGAGGTGCATCTTGTCCCATCCCAAATTCCTACCAGGAAGCACAGATGAGATTGAAAGTGTGGGGGATGGGTGCCAGGCCTTGCTTCGAGTCACACT GAGGAGCTGCTAGCATCTAAAGAAACACGAAGGAGGAAGACAGTCCATCCACAGCCCACAGCTTCCTCAGAAACACCATACCTCTGTCTCTCAGGCGCTCCCTCCTTGTTTGCGTATGTGCTTGGGAG TGAGAGACCCTCCTTCTTGTAGGCCTCGTGTATCTCAGCTGCGTTATTACCTTCAGCCCTCACAAGTGCCGGGGTCAGACGGTTCCATTCTGATTTTACAGAGAGGAGTGACTGAGCCTGGGCTTCTG TCTGAGCTTCCAGGCTCAGATATTGGTCTATGGTGCCCTGAATGCTCACCATTGTGCCACAGTGTCCGAAGCACACTGTGGGACTTGAGTTCTCAATGGCCCCAGCTCCTTCCCATTTCAGCATTTTC CATGTTACTGATTGCTGGATGACCCCCCCTCCTTCTTTCTTTTCAGTGAGCAGCATGCTTTCCTTCCCTCATAGACAGGCAGACCTCTCCCCTTCACCCTACACCCTTGCCACTGGCCACATCAACCT CTAAGAGCTGGGACAGGGTTCAACCAAGTTCCATTTCCACGAGACAGGTCTCATTCTCTTGGCAGACAAAACCAGCAAAATACAGGTCTAAGCCATGACTCTTCCACCCGTCAAGCCACCCTTAATGG ATGGATGGCTGTGATGAACCATAGAGGCAGAGACGGTTTCCTGAGCCCCGGATCTTTCTCCCTTCTGGAACTATTCCGCCATACGTACTTGTCTCTTGAGAATCCCCGCATCATGGACCTCATCGGGC TGCTGAAGTCCCAGTTTCTGTGTCACCTGGTCTTCTGCTACGTGTTCATCGCCTCCGGGCTCATTGTCAACGCCATCCAGCTGTGCACGCTGGTCATCTGGCCCATCAACAAGCAGCTGTTCCGAAAG ATAAACGCCAGACTCTGCTACTGCGTCTCCAGCCAGTTGGTGATGCTTCTGGAGTGGTGGTCAGGTACGGAGTGTACCATCTACACCGACCCGAAGGCCTCCCCCCACTACGGGAAGGAAAACGCCAT CGTGGTTCTCAATCACAAGTTTGAGATTGACTTTCTCTGTGGCTGGAGCCTGGCTGAGCGCCTAGGGATCCTGGGGAACTCCAAAGTCCTGGCCAAGAAAGAACTGGCTTATGTCCCCATCATTGGCT GGATGTGGTACTTTGTGGAAATGATCTTCTGCACACGCAAGTGGGAGCAAGATCGGCAGACGGTTGCCAAGAGCCTGCTGCACCTCCGGGACTACCCAGAGAAGTATCTGTTTCTGATCCACTGTGAG GGCACACGGTTCACAGAGAAGAAACACCAAATCAGCATGCAGGTAGCCCAAGCCAAGGGGCTGCCCAGCCTCAAGCATCACCTGCTGCCACGCACCAAGGGCTTTGCTATCACTGTGAAGTGCTTGCG AGATGTTGTCCCAGCCGTATATGACTGTACACTCAATTTCAGAAACAATGAAAACCCAACACTGCTGGGAGTCTTAAATGGAAAGAAATATCACGCTGACTGCTACGTTAGGAGGATCCCCATGGAAG ACATCCCTGAGGATGAGGACAAGTGCTCAGCCTGGCTACACAAGCTCTACCAGGAGAAGGATGCCTTTCAGGAGGAATACTACAGGACAGGGGTCTTCCCAGAGACTCCCTGGGTTCCCCCACGGCGG CCCTGGTCTCTGGTCAACTGGTTGTTCTGGGCGTCGCTGCTGCTCTATCCTTTCTTCCAGTTCCTTGTTAGCATGGTCAGCAGCGGTTCCTCGGTGACGCTGGCCAGCTTGGTCCTCATCTTCTGCAT GGCCTCCATGGGAGTTCGATGGATGATTGGTGTGACAGAAATCGACAAGGGCTCTGCCTATGGCAACATCGACAACAAACGGAAACAAACTGACTGATGTGGAAAATGTCACCTCCAAAGGGAACCGT GGGGGACAGTTGGCCTCTGCTTAGCCTTTATAGCAGGGTTCAGTGATGGAGACTGGAGGGCCTTGCTGGGACAAACAGAAACCACAGCCCCTCCAGTCATGGAGTTTGCCTTGGCGCTGGATGGGAAA GGAAGATGGTTTTATACCTTTCCCCTCCCCCATCCCCGTGTGAATTACTGGGTTTGGTTACGTTTCTTTTCAGTTGCACACGTGTTTGTGTGTATGTGTGTGTGAGAGAGATGGGGGTGAGGAGAATG AGTGTGTGGTTGCGTGTGCACTTGTGACCCTGTGACAGTAGGGTCTGTGAGGCTGCAGGGAAGGGCAGGGCTGGGGTGGAAGAGAAGGTGTGTGTCCCTGTCATCCCGTGGTGCTGCGTCTTCTCTAA CCATCGATCGCTGGAGACGGAGTGAAGTGTTTGGGTAAGACAACTAAATTATGCCTCCAAATAAGAAAAAGAATTAAAGTGTTTGTCTGGGTCATCTGTGGCAAGTATTTACACAAATCTGCTACCCC CCACCCCCACTCTTCCCTGGCTTTGGGTATTGCATATGGCAGCTTCTCACCAGCTTTGCTCCCAGTGGGGGCTGCTGAGAGCTTGAGTGAGGTGCACACACTGACAGGTCACTTGAGGGTGCGCGCGC GCGCGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTCTTAGTCACTTGTCAATGTCAGGAAGGGTTTGTTTTGGTTCACAGTTCAAGGGTACAGTCCATCATGGTGGGGGGT CATGGCAGTAGGAACGGGAAGAATCCTGTCGGTCAGAGAGAAGAGACGGATGCTGGTGCTTACCTCTCTTTCGCTCAGTTCGGAGCCCCAGCACACAGAATAGTGAAGCTATGATAGGTCCGCCCCTA TCCATCACTCTATTAGTTTAATCTAGAATCCCTTGGATTACCTGTACAGGCACAACCGGAGACTCGCCTCCTAGGTGACTCTGCATCCTGTCAACTTGACAGGCAGCATGAACCAGCACAGGATGCCA ATGCAGAGACGTGGGCGTCGGAGCCCCTCTGAGCAAGAGCCAGGACGAGGGTGCTGGGAGGCCAGCTGAGAGCTTGCTTCCAACGAGGCAGAGAGGACAGTCTGATGAGGCGGCATCCACTAGTCTTG AAGGTCTTAAGCTTTGAAACGGAATGTTATGACAACCTCAGAAACTGTCACAGGAGTGGGGAAGCTCTTAAAGCAAGGTCAGGAGCATTTTACAAAATGGAACCACGCCCCTTTTCAGCTGTCCTGTG GTACCCACTAAGGAGCCGGGTGCTACTTAAAAACACAAATGAGCCCATCTGGGGGGCTCTGCTCTCCCCCACACTGAGCTCCTGTTAGAACATGAAAGGGTGGCTGCTCTCCTCTGCAGTCTTTGGAG AATGGCCCATGGCAGACATTTGCAGACTGAGGGCAGTCAGCAGAGGCTGGATACAAACAAAACAAGAAGAAAAAGGTTAGCGTTTTAAGACGGTACCTGAAAGGTATTCGTTATAAGACGGAGAAGCT GGCAGTGCTTGGACTGATGCCCTCCTCCCTGTGTGCAGCTATGCACCACCTGGTACAACCACACACCCCCACTAGAAAAGCTGCCCATGGGGCCCACAAAGGCACATCCTGTCCAGTGTCACTGCAGA CTTAAATGTCTGTGCACCGAGTCATCAAATGGCAGCCACACAGTCAAGTGTGACTCTGACCTTGAAGAGCCAAGGGGTGACCCGGGTTCTAGAGCCCTCTGTTTAAGGGACAACGTATTATAAACACA AATAAATCTGGGCTTGCAGAAATCAGAACACCACATTCTGGGTTTTTTGTGTACCAGAGTAGACAGTGCAGGGGAGGCTGAGTTCCCACAAGGTGCTAAGCCGGGCACATCTGCCCTGCCATGCGGGC CAGAAATCACACAGAGAAAACTGGACGCTACTCTTCAGGGGACCCTGTGTTGTAGAGGCCCTGTAGGCCTCCCTTGGATCCTAAGGCCACTTTATCTGGGACCTGAGCTTGCCTTCACTGAATTCTGT GGCTTGGCCAAGTAAATATTCAATCCAGGCCATCCAGCCTCCTGACCTCCAGGGGGCCATCTGCTCAATTGTAAAATAGGAATGACACTCACCCACCCCCTGGGTTGCTGTGAGAGTGGGAAGAGGCT AACCTTGGGAAGGTAGGATCACAGAACAAATCGGGTGGAGGAATGGCAGGCGGCTTCTAAGCTGTGACTTCTCAAAGTACTTGGCAAGAACCAGACCGTGGTACAAGGCTTAGTCTCTTTGGTTTTGA CCTGTCTTTGGTGGCAGGGCAGAGACATTTTAGGTAAACTGAATGGGGAGTGGTATCTGAATGGCCTTAGAACACAAAAGGGAACAGGAGTTTGAGGGGAACCCCAGCAGCGTGCCTCAGCTGGCTGG CCTGACCTGACTCTCTCCCTAGCCCGTTTCCTTAATTCAGAGTCAGGGATTCACAGGATCCTTTGAAAAGATCTTGGCATGATGGCTACAGAACGGAGGCTCACTGAAAACCTCCACTAGGTTTTCAG AAAATCAATTGTTTTTCTATGTGCTAACAGAGACCTGGAATACATCTTAACGCCTTAATTTCTAAAGTGTGCAAAACCTTGGAAAAGTAACAGGATGTTCAAAACGTTAGAACATCTGCATCTTTCTT TATGCTCAGTGGGTGGCGGGGGGTCGGTCTGAAAGATTGATCACATTGTGGTAACTGGTTGTAGGCAGCTAAGAGTGGTGTGGCCAGTGCCAGGAAGAGCAGGACAGAGTGGGCTCAACACTGGTTTC TGAGCTTGTCCATACAGATGACAGCAATGGACAGAGCTGGCCACTGGGTTCTTCGGTCCAGGTGCCCCAAAGCACTGTGTATGTTACGGACACCTGTCAGTATGAAAGTTAAGCGAAAAATGGTGGCC CCTGGGCTCAGCAAGCCCCCGGCAGGACCAGGACAGTCTGGAGGAGTGCAGAGTGCTGTCGGGACGTGTATGGGAGTTGGAGTTTGAAAGGGGAAAGATGGACGGCATACAGCTAAGGCTGCCTTATG GCCACCTGTTCTCCCGGGGCACTGCGGAAAGCACTCCCCAAGTTTAATGTCGTAAGTGGTTTGAAGCCTGGAGAGTGAAGTAGGGCAGATGCAAACATGGCGCTTGTCTCCCTCTGACACTTCAGGGG GCTGAGCCGTGTCACAGGGACTGCCAGTCAAGGCCTCAGGACCAACTCACGTGGCAGTTTTAGTAACCGTCTGGATGCAGAGGTTCCAGTGTCTACACCGCCGTGAGCCTGCTGCCCCTTTCCAGGTC TGTATGATTTGCTGTCCCTGCAGACCCGCTGTGTTCAAAAGGGATGGTCAGCAGTGACAACCACGGTCTCTCGGACTTGTCTTCGCCTCTTCCAAGCCTCGGACAGTTGCTTACATGTTTGTTGTTGG GATTCTTCCTCACATACATAAACATCGAGTGTTTGAAGATATCAGAAATTGTTTCCCCATAATTGGGCAACTTTCTGAAAATGTTTTCCCAGACTTCCTTGGAGACTGTTTCTTCTTTTATTAGAATG AACGAAGCTGACCCTCGGAGTGCAAGCTGGGGCAGAAGGGTTTAGCTAGGTCCCTCTGTCCACAGACAAGTCAGGAAGGCAAGGGGCTCCATCAGCACAGAACCCCAGGCCTGCCTGCTGACCAACAC CTCATATGCACTGCATAACCACGCCAGCCCCACCTAATCGCATCCCCAGAGCCGTGCGTACATGGACTCTGGCTCAAGTGCTTCTTGACTTAAAATTTCACCGAAAGCCGAACCGTGCTTTGATCTAC CCTGCACCCGACATGACAAGAGGAGCCAAAGGCCTGAGGGAGTGACTGGATTATTGCTGGGCCCCAGACACCCAACATTACTCAAGGCACCGGATACCAACCTGCAAAAGACCTGTTTCGTGATATCT GACTGTTCAGAACTATTGTTTTGGTCAAGAACACAGCATATAAAATGC
hide sequence
RefSeq Acc Id:
XM_006227857 ⟹ XP_006227919
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 51,075,081 - 51,181,548 (-) NCBI mRatBN7.2 1 48,525,131 - 48,633,798 (-) NCBI Rnor_6.0 1 48,716,094 - 48,826,292 (-) NCBI Rnor_5.0 1 50,929,133 - 51,035,499 (+) NCBI
Sequence:
GAAAGCTGTTTGCCGCGTTTCTGCAGCCCTGAGAAATTCACCAGTACTGCTTACGCATGGAGAG AGTACAGTGACCACCGGGGCATTCTTTTTTGTAAATACGTAAACATCTGCGGACGGTGTCTTGAACAACGTGTATTTGAAGGGCACTTTAAGGCACCCAGCGATTGAAGCCACCTTCCCAGGAATGTC ACAGACCTGGCCTTGGCGTACTTCCAACAATCACCCTCCTTAAAGTTTCGTGACTCTATTCGGTTAAGAAGGTCTGCTCAGACCCTAGCTAATTTAACCGGAGTGTGAATGCCATGTGCACGTGCGTG TTGCCTGCTTGTGCGCACTCGCAGCGGTAGCCAGCTCTGGCAACCGGCTGGCACCTAGCTTTGGAGGGAGAGCATCTATACACAGGAGCTCCAGGCATCCCAGGTCTGCCGGTCTCAGTCTCGGGAGC GCTGGGCTTCCGGGCTGGTGGAGTGGTGGCCAGGAGAGACGGTTTCCTGAGCCCCGGATCTTTCTCCCTTCTGGAACTATTCCGCCATACGTACTTGTCTCTTGAGAATCCCCGCATCATGGACCTCA TCGGGCTGCTGAAGTCCCAGTTTCTGTGTCACCTGGTCTTCTGCTACGTGTTCATCGCCTCCGGGCTCATTGTCAACGCCATCCAGCTGTGCACGCTGGTCATCTGGCCCATCAACAAGCAGCTGTTC CGAAAGATAAACGCCAGACTCTGCTACTGCGTCTCCAGCCAGTTGGTGATGCTTCTGGAGTGGTGGTCAGGTACGGAGTGTACCATCTACACCGACCCGAAGGCCTCCCCCCACTACGGGAAGGAAAA CGCCATCGTGGTTCTCAATCACAAGTTTGAGATTGACTTTCTCTGTGGCTGGAGCCTGGCTGAGCGCCTAGGGATCCTGGGGAACTCCAAAGTCCTGGCCAAGAAAGAACTGGCTTATGTCCCCATCA TTGGCTGGATGTGGTACTTTGTGGAAATGATCTTCTGCACACGCAAGTGGGAGCAAGATCGGCAGACGGTTGCCAAGAGCCTGCTGCACCTCCGGGACTACCCAGAGAAGTATCTGTTTCTGATCCAC TGTGAGGGCACACGGTTCACAGAGAAGAAACACCAAATCAGCATGCAGGTAGCCCAAGCCAAGGGGCTGCCCAGCCTCAAGCATCACCTGCTGCCACGCACCAAGGGCTTTGCTATCACTGTGAAGTG CTTGCGAGATGTTGTCCCAGCCGTATATGACTGTACACTCAATTTCAGAAACAATGAAAACCCAACACTGCTGGGAGTCTTAAATGGAAAGAAATATCACGCTGACTGCTACGTTAGGAGGATCCCCA TGGAAGACATCCCTGAGGATGAGGACAAGTGCTCAGCCTGGCTACACAAGCTCTACCAGGAGAAGGATGCCTTTCAGGAGGAATACTACAGGACAGGGGTCTTCCCAGAGACTCCCTGGGTTCCCCCA CGGCGGCCCTGGTCTCTGGTCAACTGGTTGTTCTGGGCGTCGCTGCTGCTCTATCCTTTCTTCCAGTTCCTTGTTAGCATGGTCAGCAGCGGTTCCTCGGTGACGCTGGCCAGCTTGGTCCTCATCTT CTGCATGGCCTCCATGGGAGTTCGATGGATGATTGGTGTGACAGAAATCGACAAGGGCTCTGCCTATGGCAACATCGACAACAAACGGAAACAAACTGACTGATGTGGAAAATGTCACCTCCAAAGGG AACCGTGGGGGACAGTTGGCCTCTGCTTAGCCTTTATAGCAGGGTTCAGTGATGGAGACTGGAGGGCCTTGCTGGGACAAACAGAAACCACAGCCCCTCCAGTCATGGAGTTTGCCTTGGCGCTGGAT GGGAAAGGAAGATGGTTTTATACCTTTCCCCTCCCCCATCCCCGTGTGAATTACTGGGTTTGGTTACGTTTCTTTTCAGTTGCACACGTGTTTGTGTGTATGTGTGTGTGAGAGAGATGGGGGTGAGG AGAATGAGTGTGTGGTTGCGTGTGCACTTGTGACCCTGTGACAGTAGGGTCTGTGAGGCTGCAGGGAAGGGCAGGGCTGGGGTGGAAGAGAAGGTGTGTGTCCCTGTCATCCCGTGGTGCTGCGTCTT CTCTAACCATCGATCGCTGGAGACGGAGTGAAGTGTTTGGGTAAGACAACTAAATTATGCCTCCAAATAAGAAAAAGAATTAAAGTGTTTGTCTGGGTCATCTGTGGCAAGTATTTACACAAATCTGC TACCCCCCACCCCCACTCTTCCCTGGCTTTGGGTATTGCATATGGCAGCTTCTCACCAGCTTTGCTCCCAGTGGGGGCTGCTGAGAGCTTGAGTGAGGTGCACACACTGACAGGTCACTTGAGGGTGC GCGCGCGCGCGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTCTTAGTCACTTGTCAATGTCAGGAAGGGTTTGTTTTGGTTCACAGTTCAAGGGTACAGTCCATCATGGTG GGGGGTCATGGCAGTAGGAACGGGAAGAATCCTGTCGGTCAGAGAGAAGAGACGGATGCTGGTGCTTACCTCTCTTTCGCTCAGTTCGGAGCCCCAGCACACAGAATAGTGAAGCTATGATAGGTCCG CCCCTATCCATCACTCTATTAGTTTAATCTAGAATCCCTTGGATTACCTGTACAGGCACAACCGGAGACTCGCCTCCTAGGTGACTCTGCATCCTGTCAACTTGACAGGCAGCATGAACCAGCACAGG ATGCCAATGCAGAGACGTGGGCGTCGGAGCCCCTCTGAGCAAGAGCCAGGACGAGGGTGCTGGGAGGCCAGCTGAGAGCTTGCTTCCAACGAGGCAGAGAGGACAGTCTGATGAGGCGGCATCCACTA GTCTTGAAGGTCTTAAGCTTTGAAACGGAATGTTATGACAACCTCAGAAACTGTCACAGGAGTGGGGAAGCTCTTAAAGCAAGGTCAGGAGCATTTTACAAAATGGAACCACGCCCCTTTTCAGCTGT CCTGTGGTACCCACTAAGGAGCCGGGTGCTACTTAAAAACACAAATGAGCCCATCTGGGGGGCTCTGCTCTCCCCCACACTGAGCTCCTGTTAGAACATGAAAGGGTGGCTGCTCTCCTCTGCAGTCT TTGGAGAATGGCCCATGGCAGACATTTGCAGACTGAGGGCAGTCAGCAGAGGCTGGATACAAACAAAACAAGAAGAAAAAGGTTAGCGTTTTAAGACGGTACCTGAAAGGTATTCGTTATAAGACGGA GAAGCTGGCAGTGCTTGGACTGATGCCCTCCTCCCTGTGTGCAGCTATGCACCACCTGGTACAACCACACACCCCCACTAGAAAAGCTGCCCATGGGGCCCACAAAGGCACATCCTGTCCAGTGTCAC TGCAGACTTAAATGTCTGTGCACCGAGTCATCAAATGGCAGCCACACAGTCAAGTGTGACTCTGACCTTGAAGAGCCAAGGGGTGACCCGGGTTCTAGAGCCCTCTGTTTAAGGGACAACGTATTATA AACACAAATAAATCTGGGCTTGCAGAAATCAGAACACCACATTCTGGGTTTTTTGTGTACCAGAGTAGACAGTGCAGGGGAGGCTGAGTTCCCACAAGGTGCTAAGCCGGGCACATCTGCCCTGCCAT GCGGGCCAGAAATCACACAGAGAAAACTGGACGCTACTCTTCAGGGGACCCTGTGTTGTAGAGGCCCTGTAGGCCTCCCTTGGATCCTAAGGCCACTTTATCTGGGACCTGAGCTTGCCTTCACTGAA TTCTGTGGCTTGGCCAAGTAAATATTCAATCCAGGCCATCCAGCCTCCTGACCTCCAGGGGGCCATCTGCTCAATTGTAAAATAGGAATGACACTCACCCACCCCCTGGGTTGCTGTGAGAGTGGGAA GAGGCTAACCTTGGGAAGGTAGGATCACAGAACAAATCGGGTGGAGGAATGGCAGGCGGCTTCTAAGCTGTGACTTCTCAAAGTACTTGGCAAGAACCAGACCGTGGTACAAGGCTTAGTCTCTTTGG TTTTGACCTGTCTTTGGTGGCAGGGCAGAGACATTTTAGGTAAACTGAATGGGGAGTGGTATCTGAATGGCCTTAGAACACAAAAGGGAACAGGAGTTTGAGGGGAACCCCAGCAGCGTGCCTCAGCT GGCTGGCCTGACCTGACTCTCTCCCTAGCCCGTTTCCTTAATTCAGAGTCAGGGATTCACAGGATCCTTTGAAAAGATCTTGGCATGATGGCTACAGAACGGAGGCTCACTGAAAACCTCCACTAGGT TTTCAGAAAATCAATTGTTTTTCTATGTGCTAACAGAGACCTGGAATACATCTTAACGCCTTAATTTCTAAAGTGTGCAAAACCTTGGAAAAGTAACAGGATGTTCAAAACGTTAGAACATCTGCATC TTTCTTTATGCTCAGTGGGTGGCGGGGGGTCGGTCTGAAAGATTGATCACATTGTGGTAACTGGTTGTAGGCAGCTAAGAGTGGTGTGGCCAGTGCCAGGAAGAGCAGGACAGAGTGGGCTCAACACT GGTTTCTGAGCTTGTCCATACAGATGACAGCAATGGACAGAGCTGGCCACTGGGTTCTTCGGTCCAGGTGCCCCAAAGCACTGTGTATGTTACGGACACCTGTCAGTATGAAAGTTAAGCGAAAAATG GTGGCCCCTGGGCTCAGCAAGCCCCCGGCAGGACCAGGACAGTCTGGAGGAGTGCAGAGTGCTGTCGGGACGTGTATGGGAGTTGGAGTTTGAAAGGGGAAAGATGGACGGCATACAGCTAAGGCTGC CTTATGGCCACCTGTTCTCCCGGGGCACTGCGGAAAGCACTCCCCAAGTTTAATGTCGTAAGTGGTTTGAAGCCTGGAGAGTGAAGTAGGGCAGATGCAAACATGGCGCTTGTCTCCCTCTGACACTT CAGGGGGCTGAGCCGTGTCACAGGGACTGCCAGTCAAGGCCTCAGGACCAACTCACGTGGCAGTTTTAGTAACCGTCTGGATGCAGAGGTTCCAGTGTCTACACCGCCGTGAGCCTGCTGCCCCTTTC CAGGTCTGTATGATTTGCTGTCCCTGCAGACCCGCTGTGTTCAAAAGGGATGGTCAGCAGTGACAACCACGGTCTCTCGGACTTGTCTTCGCCTCTTCCAAGCCTCGGACAGTTGCTTACATGTTTGT TGTTGGGATTCTTCCTCACATACATAAACATCGAGTGTTTGAAGATATCAGAAATTGTTTCCCCATAATTGGGCAACTTTCTGAAAATGTTTTCCCAGACTTCCTTGGAGACTGTTTCTTCTTTTATT AGAATGAACGAAGCTGACCCTCGGAGTGCAAGCTGGGGCAGAAGGGTTTAGCTAGGTCCCTCTGTCCACAGACAAGTCAGGAAGGCAAGGGGCTCCATCAGCACAGAACCCCAGGCCTGCCTGCTGAC CAACACCTCATATGCACTGCATAACCACGCCAGCCCCACCTAATCGCATCCCCAGAGCCGTGCGTACATGGACTCTGGCTCAAGTGCTTCTTGACTTAAAATTTCACCGAAAGCCGAACCGTGCTTTG ATCTACCCTGCACCCGACATGACAAGAGGAGCCAAAGGCCTGAGGGAGTGACTGGATTATTGCTGGGCCCCAGACACCCAACATTACTCAAGGCACCGGATACCAACCTGCAAAAGACCTGTTTCGTG ATATCTGACTGTTCAGAACTATTGTTTTGGTCAAGAACACAGCATATAAAATGC
hide sequence
RefSeq Acc Id:
XM_063272836 ⟹ XP_063128906
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 51,075,081 - 51,148,291 (-) NCBI
RefSeq Acc Id:
NP_596897 ⟸ NM_133406
- UniProtKB:
Q924S1 (UniProtKB/Swiss-Prot), A6KJY8 (UniProtKB/TrEMBL), A0A8I6ALQ9 (UniProtKB/TrEMBL)
- Sequence:
MDLIGLLKSQFLCHLVFCYVFIASGLIVNAIQLCTLVIWPINKQLFRKINARLCYCVSSQLVMLLEWWSGTECTIYTDPKASPHYGKENAIVVLNHKFEIDFLCGWSLAERLGILGNSKVLAKKELAY VPIIGWMWYFVEMIFCTRKWEQDRQTVAKSLLHLRDYPEKYLFLIHCEGTRFTEKKHQISMQVAQAKGLPSLKHHLLPRTKGFAITVKCLRDVVPAVYDCTLNFRNNENPTLLGVLNGKKYHADCYVR RIPMEDIPEDEDKCSAWLHKLYQEKDAFQEEYYRTGVFPETPWVPPRRPWSLVNWLFWASLLLYPFFQFLVSMVSSGSSVTLASLVLIFCMASMGVRWMIGVTEIDKGSAYGNIDNKRKQTD
hide sequence
RefSeq Acc Id:
XP_006227919 ⟸ XM_006227857
- Peptide Label:
isoform X2
- UniProtKB:
Q924S1 (UniProtKB/Swiss-Prot), A6KJY8 (UniProtKB/TrEMBL), A0A8I6ALQ9 (UniProtKB/TrEMBL)
- Sequence:
MDLIGLLKSQFLCHLVFCYVFIASGLIVNAIQLCTLVIWPINKQLFRKINARLCYCVSSQLVMLLEWWSGTECTIYTDPKASPHYGKENAIVVLNHKFEIDFLCGWSLAERLGILGNSKVLAKKELAY VPIIGWMWYFVEMIFCTRKWEQDRQTVAKSLLHLRDYPEKYLFLIHCEGTRFTEKKHQISMQVAQAKGLPSLKHHLLPRTKGFAITVKCLRDVVPAVYDCTLNFRNNENPTLLGVLNGKKYHADCYVR RIPMEDIPEDEDKCSAWLHKLYQEKDAFQEEYYRTGVFPETPWVPPRRPWSLVNWLFWASLLLYPFFQFLVSMVSSGSSVTLASLVLIFCMASMGVRWMIGVTEIDKGSAYGNIDNKRKQTD
hide sequence
RefSeq Acc Id:
XP_006227918 ⟸ XM_006227856
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2JWH4 (UniProtKB/TrEMBL), A0A8I6ALQ9 (UniProtKB/TrEMBL)
- Sequence:
MAVMNHRGRDGFLSPGSFSLLELFRHTYLSLENPRIMDLIGLLKSQFLCHLVFCYVFIASGLIVNAIQLCTLVIWPINKQLFRKINARLCYCVSSQLVMLLEWWSGTECTIYTDPKASPHYGKENAIV VLNHKFEIDFLCGWSLAERLGILGNSKVLAKKELAYVPIIGWMWYFVEMIFCTRKWEQDRQTVAKSLLHLRDYPEKYLFLIHCEGTRFTEKKHQISMQVAQAKGLPSLKHHLLPRTKGFAITVKCLRD VVPAVYDCTLNFRNNENPTLLGVLNGKKYHADCYVRRIPMEDIPEDEDKCSAWLHKLYQEKDAFQEEYYRTGVFPETPWVPPRRPWSLVNWLFWASLLLYPFFQFLVSMVSSGSSVTLASLVLIFCMA SMGVRWMIGVTEIDKGSAYGNIDNKRKQTD
hide sequence
Ensembl Acc Id:
ENSRNOP00000069883 ⟸ ENSRNOT00000082958
Ensembl Acc Id:
ENSRNOP00000024213 ⟸ ENSRNOT00000024213
Ensembl Acc Id:
ENSRNOP00000094231 ⟸ ENSRNOT00000117069
RefSeq Acc Id:
XP_063128906 ⟸ XM_063272836
- Peptide Label:
isoform X3
RGD ID: 13689623
Promoter ID: EPDNEW_R148
Type: initiation region
Name: Agpat4_1
Description: 1-acylglycerol-3-phosphate O-acyltransferase 4
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 1 48,825,331 - 48,825,391 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2013-02-13
Agpat4
1-acylglycerol-3-phosphate O-acyltransferase 4
Agpat4
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-11-17
Agpat4
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)
1-acylglycerol-3-phosphate O-acyltransferase 4
Name updated
1299863
APPROVED
2004-12-14
Agpat4
1-acylglycerol-3-phosphate O-acyltransferase 4
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, delta)
Name updated
1299863
APPROVED
2002-08-07
Agpat4
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, delta)
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_function
converts lysophosphatidic acid (lpa) into phosphatidic acid by incorporating acyl moiety at the 2 position
724707